Chicago, March 1, 2023 — Sharon K. Inouye, M.D., M.P.H., Professor of Medicine at Harvard Medical School and the Milton and Shirley F. Levy Family Chair and Director of the Aging Brain Center, Marcus Institute for Aging Research at Hebrew SeniorLife has been named the editor in chief of JAMA Internal Medicine.
Credit: JAMA Network
Chicago, March 1, 2023 — Sharon K. Inouye, M.D., M.P.H., Professor of Medicine at Harvard Medical School and the Milton and Shirley F. Levy Family Chair and Director of the Aging Brain Center, Marcus Institute for Aging Research at Hebrew SeniorLife has been named the editor in chief of JAMA Internal Medicine.
An internationally recognized leader in internal medicine, geriatrics, and aging research, Dr. Inouye’s research focuses on delirium and functional decline in hospitalized older patients. She is currently the overall principal investigator of the Successful Aging after Elective Surgery (SAGES) study, a $13 million Program Project on delirium and dementia funded by the National Institute on Aging, as well as other active research projects. She is an elected member of the National Academy of Medicine. She previously served as an Associate Editor at JAMA Network Open. Dr. Inouye succeeds Rita F. Redberg, M.D., M.Sc., who has been editor in chief of JAMA Internal Medicine since 2009.
“I am truly excited to become the next editor in chief of JAMA Internal Medicine. I hope to build on the tremendous foundation provided by Dr. Rita Redberg and her team,” said Dr. Inouye. “My vision is that JAMA Internal Medicine will provide a voice and sounding board for the internal medicine community worldwide. I believe the journal will provide the essential evidence and knowledge base to advance the field of medicine, to influence practice and policy globally, and to improve public health for all.”
Dr. Inouye will assume this position on July 1, 2023. JAMA Internal Medicine is a leading, international peer-reviewed journal providing innovative and clinically relevant research for practitioners in general internal medicine and internal medicine subspecialties. JAMA Internal Medicine receives approximately 3,400 submissions per year with an overall acceptance rate of 11% and 4% for research and has wide global reach with 14 million article views per year and an impact factor of 44.4.
“I am delighted to welcome Dr. Inouye as the next editor in chief of JAMA Internal Medicine,” said Kirsten Bibbins-Domingo, M.D., Ph.D., M.A.S., editor in chief of JAMA and the JAMA Network. “JAMA Internal Medicine has had a remarkable growth under Dr. Redberg’s leadership, and I am grateful for her contributions to the JAMA Network. I look forward to working with Dr. Inouye and am confident that her expertise, experience, and vision for internal medicine research, clinical practice, and medical communications will be a tremendous asset to JAMA Internal Medicine authors and readers.”
About The JAMA Network®
The JAMA Network brings JAMA together with JAMA Network Open and 11 specialty journals to offer enhanced access to the educational content, scientific research, and opinion shaping the future of medicine. Published continuously since 1883, JAMA is one of the most widely circulated, peer-reviewed, general medical journals in the world.
